CVS CEO sees bonus reduced due to opioid settlement


Karen Lynch was not CEO during the years CVS was accused of helping to fuel the nation's opioid crisis but took a $1.5 million reduction in her non-equity incentive pay for 2022.

Previous Healey says abortion medication will remain protected in Mass., orders pills to be stockpiled
Next 'Any medicine is at risk': Biotech execs condemn judicial overturning of abortion pill approval